HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Krainer Selected Research

cabozantinib

1/2016Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Krainer Research Topics

Disease

24Neoplasms (Cancer)
01/2022 - 03/2004
19Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2007
17Ovarian Neoplasms (Ovarian Cancer)
02/2020 - 05/2005
7Disease Progression
01/2022 - 03/2004
6Breast Neoplasms (Breast Cancer)
01/2021 - 03/2004
3Neoplasm Metastasis (Metastasis)
12/2020 - 09/2002
3Pain (Aches)
05/2015 - 01/2008
2Circulating Neoplastic Cells
01/2016 - 12/2010
2Fatigue
05/2015 - 06/2014
2Carcinoma (Carcinomatosis)
12/2007 - 12/2005
1Frailty
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Sarcopenia
01/2020
1Thrombocytopenia (Thrombopenia)
03/2018
1Anemia
03/2018
1Fistula
12/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2017
1Kidney Neoplasms (Kidney Cancer)
01/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1Asthenia
05/2015
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2015
1Leiomyosarcoma
01/2015
1Colitis
06/2014
1Endometrial Neoplasms (Endometrial Cancer)
12/2010
1Carcinogenesis
05/2010
1Ovarian Epithelial Carcinoma
12/2005

Drug/Important Bio-Agent (IBA)

8Docetaxel (Taxotere)FDA Link
12/2020 - 06/2007
6Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015 - 06/2005
4Hormones (Hormone)IBA
01/2018 - 03/2007
4LigandsIBA
03/2011 - 06/2005
3AndrogensIBA
01/2022 - 06/2007
3Drug CombinationsIBA
01/2021 - 11/2018
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2007
3Biological ProductsIBA
01/2021 - 12/2014
3Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2014
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
03/2011 - 05/2005
3CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
03/2011 - 12/2005
3Trastuzumab (Herceptin)FDA Link
02/2005 - 03/2004
2Androgen Receptors (Androgen Receptor)IBA
01/2022 - 01/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2016
2IpilimumabIBA
12/2020 - 06/2014
2Taxoids (Taxanes)IBA
01/2020 - 12/2018
2Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 01/2016
2cabazitaxelFDA Link
12/2018 - 01/2018
2Bevacizumab (Avastin)FDA Link
12/2017 - 01/2017
2NivolumabIBA
01/2017 - 01/2016
2Messenger RNA (mRNA)IBA
03/2013 - 05/2010
2Death Domain ReceptorsIBA
03/2011 - 12/2005
2Protein Isoforms (Isoforms)IBA
06/2010 - 12/2007
2AntibodiesIBA
01/2008 - 12/2007
1SuspensionsIBA
01/2022
1Tumor Viral Antigens (Large T Antigen)IBA
01/2022
1Testosterone (Sustanon)FDA Link
01/2022
1Androgen Antagonists (Antiandrogens)IBA
01/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1cabozantinibIBA
01/2016
1Pharmaceutical PreparationsIBA
01/2016
1taxaneIBA
05/2015
1Analgesics (Analgesic Drugs)IBA
05/2015
1TNF-Related Apoptosis-Inducing LigandIBA
05/2015
1C-Reactive ProteinIBA
01/2015
1Dihydrotachysterol (AT 10)IBA
06/2014
1Sunitinib (Sutent)FDA Link
01/2014
1TransferasesIBA
04/2013
1dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA
04/2013
1Tetracycline (Achromycin)FDA LinkGeneric
12/2011
1Lapatinib (GW572016)FDA Link
12/2011
1Cetuximab (Erbitux)FDA Link
12/2011
1CollagenIBA
12/2011
1Epithelial Cell Adhesion MoleculeIBA
12/2010
1AntigensIBA
12/2010
1RNA (Ribonucleic Acid)IBA
12/2010
1Protein CIBA
06/2010
1EnzymesIBA
06/2010
1Transforming Growth Factor beta (TGF-beta)IBA
05/2010
1Carboplatin (JM8)FDA LinkGeneric
04/2010
1AutoantigensIBA
01/2008
1EpitopesIBA
01/2008
1Small Interfering RNA (siRNA)IBA
12/2007
1UbiquitinIBA
12/2007
1Ligases (Synthetase)IBA
12/2007
1Cytotoxins (Cytolysins)IBA
06/2007
1Vinorelbine (Navelbine)FDA LinkGeneric
06/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2005
1DecitabineFDA Link
06/2005

Therapy/Procedure

18Therapeutics
01/2022 - 03/2004
14Castration
01/2022 - 08/2012
5Drug Therapy (Chemotherapy)
12/2017 - 02/2005
4Radiotherapy
12/2020 - 01/2008
2Salvage Therapy
01/2017 - 01/2016
2Neoadjuvant Therapy
01/2008 - 03/2004
1Precision Medicine
02/2020
1Art Therapy
01/2020
1Duration of Therapy
01/2020
1Brachytherapy
12/2017
1Chemoradiotherapy
12/2017